tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aptose Biosciences Reports Promising Q2 2025 Results
PremiumCompany AnnouncementsAptose Biosciences Reports Promising Q2 2025 Results
2M ago
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
Premium
Company Announcements
Aptose Biosciences Advances Tuspetinib in AML Treatment with Promising Trial Results
2M ago
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
Premium
Company Announcements
Aptose Biosciences Advances TUSCANY Trial with Dose Escalation
2M ago
Aptose Biosciences Secures $8.5M Loan Agreement
PremiumCompany AnnouncementsAptose Biosciences Secures $8.5M Loan Agreement
3M ago
Aptose Biosciences Secures $8.5M Loan for AML Therapy
Premium
Company Announcements
Aptose Biosciences Secures $8.5M Loan for AML Therapy
3M ago
Aptose Biosciences Secures Cash Advance Amid Financial Uncertainty
Premium
Company Announcements
Aptose Biosciences Secures Cash Advance Amid Financial Uncertainty
3M ago
Aptose Biosciences Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsAptose Biosciences Reports Q1 2025 Financial Results
5M ago
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
Premium
Company Announcements
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
5M ago
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
Premium
Company Announcements
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100